Literature DB >> 16912436

Molecular epidemiology of clinical isolates of ampc producing Klebsiella pneumoniae.

V Manchanda1, N P Singh, A Shamweel, H K Eideh, S S Thukral.   

Abstract

PURPOSE: AmpC producing K. pneumoniae have been increasingly reported from India but epidemiological studies are lacking. In the present study, molecular epidemiology of extended-spectrum AmpC beta-lactamases (ESACs) producing clinical isolates of K. pneumoniae prevalent in our hospital was studied.
METHODS: Fifty-one non-repeat, consecutive, clinical isolates of K. pneumoniae producing AmpC enzymes, were subjected to whole cell protein profile analysis (SDS-PAGE) and ribotyping. The antimicrobial susceptibility was determined using standard disk diffusion technique. The isolates showing decreased susceptibility to cefoxitin (< 18 mm) or cefotetan (< 16 mm) were subjected to modified three- dimensional test for detection of AmpC enzyme.
RESULTS: Six different types of protein profiles were observed. Ribotyping could further discriminate between the strains that were clustered by protein fingerprinting. Twelve different ribo-patterns were identified. Ribotyping was found to have a better Discriminatory Index (0.98) than that of SDS-PAGE (0.78). Of the 26 isolates that showed decreased susceptibility to cefoxitin and/or cefotetan 13 isolates were found to harbour AmpC enzyme.
CONCLUSIONS: The study demonstrated the usefulness of SDS-PAGE whole cell protein profile analysis and ribotyping to identify the clonality of the ESACs isolates, the latter having a higher discriminatory power. The presence of ESACs isolates in the community as well as in hospital settings emphasizes the need for regular monitoring of antimicrobial resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912436

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  9 in total

1.  Antibiotic susceptibility pattern in urinary isolates of gram negative bacilli with special reference to AmpC β-lactamase in a tertiary care hospital.

Authors:  Mitesh H Patel; Grishma R Trivedi; Sachin M Patel; Mahendra M Vegad
Journal:  Urol Ann       Date:  2010-01

2.  Occurrence of extended-spectrum and AmpC β-lactamases in multiple drug resistant Salmonella isolates from clinical samples in Lagos, Nigeria.

Authors:  K O Akinyemi; Bamidele Abiodun Iwalokun; Akeeb O Bola Oyefolu; C O Fakorede
Journal:  Infect Drug Resist       Date:  2017-01-13       Impact factor: 4.003

3.  Detection of AmpC β-lactamase producing bacteria isolated in neonatal sepsis.

Authors:  Sonia Salamat; Hasan Ejaz; Aizza Zafar; Humera Javed
Journal:  Pak J Med Sci       Date:  2016 Nov-Dec       Impact factor: 1.088

4.  Molecular Characterization of Extended Spectrum β-lactamase and Carbapenemase Producing Klebsiella pneumoniae from a Tertiary Care Hospital.

Authors:  Beena Hosdurg Bhaskar; Shalini Shenoy Mulki; Sangeetha Joshi; Ranjeeta Adhikary; Bhavana Malavalli Venkatesh
Journal:  Indian J Crit Care Med       Date:  2019-02

5.  First Detection of FOX-1 AmpC β-lactamase Gene Expression Among Escherichia coli Isolated from Abattoir Samples in Abakaliki, Nigeria.

Authors:  Ejikeugwu Chika; Esimone Charles; Iroha Ifeanyichukwu; Adikwu Michael
Journal:  Oman Med J       Date:  2018-05

6.  AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India.

Authors:  Varsha Gupta; Karthikeyan Kumarasamy; Neelam Gulati; Ritu Garg; Padma Krishnan; Jagdish Chander
Journal:  Indian J Med Res       Date:  2012-08       Impact factor: 2.375

7.  Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical Centers.

Authors:  Anand Manoharan; Madhan Sugumar; Anil Kumar; Hepzibah Jose; Dilip Mathai; G C Khilnani; Arti Kapil; Geetha Francis; Kavitha Radhakrishnan; T K Dutta; S C Parija; R Narang; D K Mendiratta; Vijayshree Deotale; A K Baronia; K N Prasad
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

8.  Detection of ESBL among AmpC producing enterobacteriaceae using inhibitor-based method.

Authors:  Sasirekha Bakthavatchalu; Uma Shakthivel; Tannu Mishra
Journal:  Pan Afr Med J       Date:  2013-01-20

9.  Ampc Beta lactamases among gram negative clinical isolates from a tertiary hospital, South India.

Authors:  R Mohamudha Parveen; B N Harish; S C Parija
Journal:  Braz J Microbiol       Date:  2010-09-01       Impact factor: 2.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.